Saturday, December 20, 2014 Last update: 8:33 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

VIVUS to Present at Upcoming Investor Conference

Companies mentioned in this article: VIVUS, Inc.

MOUNTAIN VIEW, CA--(Marketwired - May 08, 2014) - VIVUS, Inc. (NASDAQ: VVUS) today announced that management will present an overview of the company at the following investor conference:

Bank of America Merrill Lynch 2014 Health Care Conference
May 14, 2014, 8:00am PDT
Encore at the Wynn, Las Vegas, NV

A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com.

About VIVUS

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2013, as amended by the Form 10-K/A filed on April 30, 2014, and periodic reports filed with the Securities and Exchange Commission.


Contact:

CONTACT :

VIVUS, Inc.
Dana B. Shinbaum
Corporate Development & Investor Relations
shinbaum@vivus.com

Investor Relations:
The Trout Group

Brian Korb
bkorb@troutgroup.com
646-378-2923